A paradigm shift in the diagnosis of prostate cancer
Season 1, Ep. 2
Inify,ContextVision’sfirst digital pathology product for diagnosis of prostate cancer using deep learning and artificial intelligence, is on track regarding commercialisation.
ContextVision just launched the Company’s first CE marked digital pathology product based on artificial intelligence using deep learning technologies. In this podcast the Company’s CEO Fredrik Palm and Dr. Filippo Fraggetta, the chief pathologist at the Cannizzaro Hospital, will talk about the revolution we are approaching within digital pathology.